Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLD5 antisense RNA 1 (PLD5-AS1) is a gene that produces a long noncoding RNA transcript, located antisense to the PLD5 (Phospholipase D family member 5) gene. The functional role of PLD5-AS1 remains uncharacterized, with no well-established biological function, disease association, or therapeutic targeting described in current public scientific literature. Unlike some other antisense or lncRNAs, PLD5-AS1 does not currently serve as a biomarker or known molecular target for any clinical intervention. Its primary classification is as a long noncoding RNA, and it may play a potential regulatory role on PLD5 gene expression, but this has not been experimentally confirmed. No information regarding drug interaction, mechanisms of action, or relevance to human disease is available in current databases or the biomedical literature. If a distinct molecular target, function, or disease relevance emerges in the future, these details should be updated accordingly. For now, PLD5-AS1 should be regarded primarily as a genomic feature, not a therapeutic target.
None known; the molecule does not act as a receptor, enzyme, or comparable drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLD5 antisense RNA 1 (PLD5-AS1).